Aslani, Baby Girl -.

HRN: 22-76-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2023
AMPICILLIN 500MG (VIAL)
03/28/2023
04/03/2023
IV
190mg
Q12
PSNB
Waiting Final Action 
03/28/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
03/28/2023
04/03/2023
IV
19mg
Q24
PSNB
Waiting Final Action 
04/23/2024
CEFUROXIME 750MG (VIAL)
04/23/2024
04/30/2024
IV
250mg
Q8H
UTI
Waiting Final Action 
04/23/2024
OXACILLIN 500MG (VIAL)
04/23/2024
04/30/2024
IV
250mg
Q6H
Staphylococcal Infection
Waiting Final Action 
04/23/2024
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
04/23/2024
04/30/2024
IV
Pea-sized
TID
Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: